-
July 31, 2018PREVIEW
Indivior PLC announced FDA approval of the first once-monthly, long-acting injectable (LAI) containing...
-
July 31, 2018PREVIEW
Astellas Pharma and Pfizer announced FDA approval of enzalutamide for treatment of men with nonmetastatic castration-resistant prostate cancer (CRPC). It is the first and only oral medication FDA...
-
July 19, 2018PREVIEW
Janssen announced FDA approval of darunavir 800 mg,...
-
July 19, 2018PREVIEW
FDA approved ribociclib in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or...
-
July 10, 2018PREVIEW
FDA approved incobotulinumtoxinA to treat chronic sialorrhea, or excessive...
Pages
